查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1837513

动物生长促进剂和性能增强剂市场（按产品类型、牲畜类型、配方、应用和分销管道划分）－2025-2032年全球预测

Animal Growth Promoters & Performance Enhancers Market by Product Type, Livestock Type, Formulation, Application, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，动物生长促进剂和性能增强剂市场规模将达到 329.8 亿美元，复合年增长率为 7.04%。

关键市场统计数据
基准年2024年 191.3亿美元
预计年份：2025年 204.7亿美元
预测年份 2032 329.8亿美元
复合年增长率 (%) 7.04%

一份策略性产业概览，揭示了监管压力、消费者期望和科学创新如何重新定义畜牧生产中的绩效改进策略

动物生长和性能增强剂产业处于动物健康、农业生产力和消费者期望的交汇点。不断增长的蛋白质需求、日益完善的动物福利标准以及抗菌药物管理倡议正在再形成价值链上相关人员的优先事项。因此，传统上专注于产量和生长的产品现在需要从安全性、残留、可追溯性和长期牛性能等方面进行评估。市场参与企业如今身处一个多层次的环境中，必须在科学的功效、监管合规性和市场准入等因素之间取得平衡。

在此背景下，创新正朝着生物目标、酶製剂和精准营养方法发展，这些方法旨在增强动物的抵抗力和饲料转化率，同时应对日益严格的抗生素使用审查。同时，商业性需求要求企业证明可衡量的成果，例如提高转换率和减少治疗性介入，以帮助生产者证明采用这些方法的合理性。这意味着该行业正从单一指标的绩效声明转向综合价值主张，将功效、安全性和可证明的投资收益相结合，从而惠及生产者和供应链合作伙伴。

监管改革、精准配送技术和消费者主导的可追溯性如何融合，重塑产品创新、伙伴关係和市场定位

重大变革正在发生，重塑竞争动态和产品开发重点。首先，许多地区监管环境的日益严格，促使人们减少预防性使用抗生素，转而采用益生元、益生菌和靶向酶等替代方案。这些日益严格的监管措施刺激了对非抗生素疗法的研究投入，这些疗法既能维持生产力，又能降低抗药性细菌的选择压力。其次，数位化精密农业工具能够更精准地控制生长促进剂的用量和监测，使干预措施能够针对特定人群和生命阶段进行调整，从而提高疗效并最大限度地减少浪费。

同时，供应链透明度和麵向消费者的永续性声明正迫使製造商核实产品的来源和残留物情况。因此，饲料添加剂製造商、基因相关企业和一体化企业之间的伙伴关係日益普遍，联合试验的重点也从单一产品推广转向整体绩效提升方案。此外，资本配置正转向生技药品和微生物解决方案，而传统化学品则在兽医监督下进行配方调整或重新定位，以适应特定用途。所有这些转变共同有利于那些能够将监管专业知识、强有力的功效数据和令人信服的商业性价值证据相结合的灵活创新者。

因应2025年关税对动物性能增强剂供应链的影响，推动区域采购、配方优化以及与战略供应商建立合作关係。

2025年关税的实施和贸易政策的调整在全球供应链中製造了新的摩擦点，并改变了生长促进剂和性能增强剂所用原料的筹资策略和成本结构。活性药物成分、特种酸和某些微生物菌株的进口关税提高，增加了依赖全球原料网路的製造商的到岸成本，促使采购团队尽可能地实现供应商多元化和供应链本地化。因此，製造商加快了对替代供应商的资格认证，并投资建设区域储备，以维持供应的连续性并减少前置作业时间波动。

此外，关税带来的成本压力促使企业重新关注配方效率和价值工程，研发团队致力于优化给药方案和浓缩液，以减少运输量和关税负担。同时，为因应投入成本波动，生产商寻求合约避险和长期供应商协议。这些因应措施也影响了它们的竞争地位。能够实现在地化生产或展现强大供应稳定性的公司赢得了大型整合商的信任，而依赖受限进口管道的公司则面临利润空间压缩，并需要加快创新以维繫客户关係。

透过整合产品化学成分、供应形式、动物生理学和管道动态等讯息，获得细分市场层面的洞察，从而揭示差异化的市场采纳路径和发展重点。

透过这种细分，我们了解到不同产品类型、牲畜类别、製剂形式、应用领域和分销管道的需求驱动因素和发展重点各不相同。产品类型动态表明，酸化剂、抗生素、β-促效剂、酵素、荷尔蒙、益生元和益生菌各自面临独特的科学、监管和市场接受度挑战。例如，酸化剂研究日益关注丁酸、甲酸和丙酸在肠道健康管理方面的应用，而抗生素则继续受到密切关注，离子载体、大环内酯类、青霉素类和四环霉素是抗菌药物管理政策的目标。莱克多巴胺和齐帕特罗等β-促效剂在某些出口市场仍存在两极化，促使生产商在疗效声明和市场准入限制之间寻求平衡。酵素的研发重点在于淀粉酶、纤维素酶、植酸酶和蛋白酶的混合物，以释放饲料中的营养物质并提高转换率。此外，以雄性激素、雌激素和黄体素为中心的荷尔蒙疗法越来越受到动物福利和残留物考虑的限制，而以微生物为中心的解决方案，包括益生元化学物质如果寡糖和甘露聚醣，以及益生菌菌株如双叉桿菌、乳酸桿菌和酵母菌，则有助于提高抗病性和生产性能。

考虑到畜牧类型，水产养殖、家禽、反刍动物和猪的生理和管理限制各不相同，这决定了产品的选择和使用策略。饲料添加剂、注射和水添加剂之间的配方选择会影响产品的推广途径和兽医的参与程度，而疾病预防、饲料转换率、生长促进和繁殖性能等方面的应用则需要不同的证据支持和研究设计。分销管道包括直销、分销商和电子商务，每种管道在控制、覆盖范围和服务水准方面各有优劣。例如，需要高度个人化支援的企业客户可能更倾向于面对面的技术支援，而小型农场则越来越多地利用数位平台来获取包装解决方案。

美洲、欧洲、中东和非洲 (EMEA) 以及亚太地区都有其独特的监管和生产实践，需要量身定制的产品文件、针对特定地区的测试以及调整后的商业化策略。

区域差异显着影响美洲、欧洲、中东和非洲以及亚太地区的监管接受度、采用率和战略重点。在美洲，生产商和监管机构在提高生产力和管理义务之间取得了务实的平衡，通常能够将新型饲料添加剂的实际应用与系统性监测相结合。相较之下，欧洲、中东和非洲地区的情况则较为复杂：欧洲的监管环境对抗生素的使用和残留限量要求严格，而中东和非洲的多个市场则为推广经济高效、耐热且适应当地生产系统的配方提供了机会。在亚太地区，高密度生产系统、技术的快速普及以及强烈的出口导向推动了对优化饲料转换率和生物安全解决方案的需求，但主导限制也可能使某些化合物的核准变得复杂。

这些地域动态会影响投资和商业化策略。面向全球市场的製造商需要设计灵活的申报资料，以适应不同的核准途径，并且必须准备好根据不同地区调整标籤和支援方案。此外，区域性研究合作和市场实地试验对于证明产品在当地条件下的表现至关重要，并能满足进口商和零售商日益增长的需求，他们要求不同产地的产品残留和福利证据必须保持一致。

竞争格局分析表明，研发驱动的差异化、策略伙伴关係和供应链韧性是动物性能解决方案领域领先地位的关键驱动因素。

竞争格局由传统製药公司、专业饲料添加剂创新企业和新兴生技公司共同组成。行业领导者通常具备强大的监管能力、广泛的测试网络以及与整合商和兽医的深厚关係，从而能够高效地将产品推向市场。同时，敏捷的生物技术公司和原料专家正在推动微生物组疗法、酵素混合物和靶向酸化剂技术的发展，迫使现有企业进行创新并获得互补能力。成熟企业与利基市场开发商之间的合作已成为缩短产品验证时间和拓展产品系列的常见策略。

此外，策略差异化也越来越依赖附加价值服务，例如数位化监测、咨询专案和综合营养方案，这些服务能够展现整体绩效的提升。投资于高品质临床数据、透明残留检测和清晰使用说明的公司，将比那些优先考虑合规性的出口导向生产商和零售商更具优势。最后，鑑于近期贸易中断和原物料价格波动，供应链​​韧性以及在地化生产或采购替代投入品的能力正成为竞争优势的来源。

製造商和经销商可采取切实可行的策略性倡议，将证据产生、供应多元化、数位化服务和监管协调相结合，以加速产品应用并降低风险。

产业领导者应优先考虑一系列切实可行的倡议，以确保商业性发展势头和监管适应能力。首先，投资进行严谨的、经同侪审查的实地研究，以证明产品具有多方面价值，例如提高饲料转换率、减少治疗性介入以及改善残留物分布。此类证据将有助于提升一体化企业和出口市场的认可度。其次，加速原料来源多元化，并评估本地生产和清关方案，以降低关税和运输风险。这些措施将有助于企业保障净利率，并确保客户获得持续稳定的供应。

第三，开发整合产品功效、数位化监控和咨询服务的组合方案，以量化结果并增强客户忠诚度。第四，与微生物组专家、酵素开发商和兽医网络进行有针对性的合作，在无需承担全部研发成本的情况下拓展技术广度。第五，透过绘製重点市场的核准途径，并在条件允许的情况下投资于统一的安全文件，来优化监管策略。结合这些步骤，企业能够在应对合规和供应链复杂性的同时，实现可衡量的绩效提升。

我们采用透明的多源研究途径，结合科学文献、法规分析、现场试验回顾和专家访谈，以确保提供可操作的产业洞察。

本分析的调查方法结合了多来源证据，包括同行评审的科学文献、监管文件、市场试验数据以及对兽医、饲料配方师和采购负责人的专家访谈。数据收集重点关注报告了受控性能结果、残留检测和跨配方功效比较的研究。调查方法还纳入了来自供应链和商业负责人的定性意见，以了解筹资策略、利润压力和分销偏好。

分析方法包括对科学发现进行主题综合、比较政策分析以梳理不同司法管辖区的监管差距，以及情境规划以评估贸易中断的营运影响。在条件允许的情况下，我们考虑了经过实地检验的参数，以评估统计稳健性和与商业性环境的相关性。在整个过程中，该方法优先考虑透明的假设和可重复的推论，以确保研究结果对技术和商业受众都具有实际应用价值。

对该行业进行全面、前瞻性的审视，强调需要严谨的证据、具有韧性的供应链和一体化的服务模式来维持长期的相关性。

总之，动物生长促进剂和性能增强剂产业正处于曲折点，监管预期、供应链现状和科学创新正在重新定义价值创造。能够用严谨的数据证明产品有效性、在贸易紧张局势下展现供应韧性、并提供符合生产者经济效益和社会期望的综合解决方案的企业，才能取得成功。随着生产者要求提供清晰的性能证据，而买家在采购决策中也越来越重视动物福利和残留物等因素，产品开发商必须调整其技术蓝图和商业性策略。

展望未来，最具永续的进步很可能来自多学科合作，这些合作将微生物组科学、精准营养和数位监测相结合，并辅以能够预见不断变化的核准标准的监管策略。那些现在就采取行动，加强证据收集、实现关键投入在地化并建立服务导向提案的公司，将更有利于在复杂的全球价值链中获得长期的相关性和信任。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 畜牧业中越来越多地采用植物来源饲料添加剂作为非抗生素生长促进剂。
  • 开发针对动物微生物组和生长性能的精准营养配方
  • 对抗生素生长促进剂的更严格监管正在推动对益生菌和有机酸等替代促进剂的需求。
  • 增加对先进酵素混合物的投资，以提高饲料转换率并减少动物生产对环境的影响
  • 基于奈米技术的靶向释放系统在禽类和猪类性能增强剂方面的进展
  • 在集约化农业环境中，对天然免疫调节剂的需求激增，以促进动物健康和生长。
  • 扩展的数据驱动型饲料优化平台，将人工智慧与生长促进剂有效性的即时动物性能分析相结合，从而提升了饲料优化平台的功能。
  • 随着 CRISPR 等基因编辑技术的出现，人们培育出了饲料转换率更高、肌肉生长潜力更大的牲畜。
  • 人们越来越重视永续性，这推动了环保性能增强剂的研发，这些增强剂可以减少反刍动物的温室气体排放。
  • 生物技术公司与饲料生产商合作，将微生物来源的生物活性胜肽商业化，用于促进动物生长。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：按产品类型分類的动物生长促进剂和性能增强剂市场

  • 酸化剂
    • 丁酸
    • 甲酸
    • 丙酸
  • 抗生素
    • 离子载体
    • 大环内酯类
    • 青霉素
    • 四环霉素
  • β-促效剂
    • 莱克多巴胺
    • 齐帕特罗
  • 酵素
    • 淀粉酶
    • 纤维素酶
    • 植酸酶
    • 蛋白酶
  • 荷尔蒙
    • 雄激素
    • 雌激素
    • 黄体素
  • 益生元
    • 寡果醣
    • 甘露聚醣
  • 益生菌
    • 双歧桿菌
    • 乳酸菌
    • 酿酒酵母

9. 按畜种分類的动物生长促进剂和性能增强剂市场

  • 水产养殖
  • 家禽
  • 反刍动物
  • 猪

第十章：按配方分類的动物生长促进剂和性能增强剂市场

  • 饲料添加剂
  • 注射
  • 水添加物

第十一章：按应用分類的动物生长促进剂和性能增强剂市场

  • 疾病预防
  • 饲料效率
  • 促进生长
  • 生育力

第十二章：按分销管道分類的动物生长促进剂和性能增强剂市场

  • 直销
  • 经销商
  • 电子商务

第十三章：按地区分類的动物生长促进剂和性能增强剂市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 动物生长促进剂和性能增强剂市场（按类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国动物生长促进剂和性能增强剂市场概况

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Elanco Animal Health Incorporated
    • Merck & Co., Inc.
    • Boehringer Ingelheim International GmbH
    • Cargill, Incorporated
    • Archer Daniels Midland Company
    • Koninklijke DSM NV
    • BASF SE
    • Evonik Industries AG
    • Alltech, Inc.
Product Code: MRR-031BF22F9499

The Animal Growth Promoters & Performance Enhancers Market is projected to grow by USD 32.98 billion at a CAGR of 7.04% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 19.13 billion
Estimated Year [2025] USD 20.47 billion
Forecast Year [2032] USD 32.98 billion
CAGR (%) 7.04%

A strategic industry overview revealing how regulatory pressure, consumer expectations, and scientific innovation are redefining performance enhancement strategies in livestock production

The animal growth promoters and performance enhancers sector sits at the intersection of animal health, agricultural productivity, and consumer expectations. Rising protein demand, evolving welfare standards, and antimicrobial stewardship initiatives have reshaped stakeholder priorities across the value chain. Consequently, products that traditionally emphasized yield and growth are increasingly evaluated against safety, residues, traceability, and long-term herd performance. Market participants now navigate a multilayered environment where science-driven efficacy must align with regulatory compliance and market access considerations.

Against this backdrop, innovation is moving toward targeted biologicals, enzyme blends, and precision nutrition approaches that support animal resilience and feed efficiency while responding to heightened scrutiny over antibiotic use. At the same time, commercial imperatives push companies to demonstrate measurable outcomes, such as improved conversion ratios and reduced therapeutic interventions, so that producers can justify adoption. In short, the industry is transitioning from single-metric performance claims toward integrated value propositions that combine efficacy, safety, and demonstrable return on investment for producers and supply-chain partners.

How a convergence of regulatory reform, precision delivery technologies, and consumer-driven traceability is reshaping product innovation, partnerships, and market positioning

Significant transformative shifts are underway that reconstitute competitive dynamics and product development priorities. First, regulatory landscapes have tightened in many jurisdictions, prompting a move away from prophylactic antibiotic use and toward alternatives such as prebiotics, probiotics, and targeted enzymes. This regulatory tightening has driven research investment into non-antibiotic modalities that can sustain productivity while reducing selection pressure for resistant organisms. Second, digital and precision agriculture tools are enabling more targeted delivery and monitoring of growth promoters, so interventions can be tailored to specific cohorts and life stages, improving efficacy and minimizing waste.

Meanwhile, supply chain transparency and consumer-facing sustainability claims are forcing manufacturers to substantiate product provenance and residue profiles. As a result, partnerships between feed additive producers, genetic companies, and integrators are becoming more common, with collaborative pilots focusing on holistic performance programs rather than discrete product placements. In addition, capital allocation has shifted toward biologics and microbiome-focused solutions, while legacy chemistries are being reformulated or repositioned for niche use under veterinary oversight. Collectively, these shifts favor agile innovators that can combine regulatory expertise, strong efficacy data, and compelling commercial evidence of value.

Navigating the 2025 tariff-induced disruption that forced regional sourcing, formulation optimization, and strategic supplier partnerships across the animal performance enhancer supply chain

The imposition of tariffs and trade policy adjustments in 2025 created new friction points for global supply chains, altering sourcing strategies and cost structures for inputs used in growth promoters and performance enhancers. Elevated import duties on active pharmaceutical ingredients, specialty acids, and certain microbial strains increased landed costs for manufacturers that rely on global raw material networks, prompting procurement teams to diversify suppliers and regionalize supply chains where feasible. As a result, manufacturers accelerated qualification of alternate suppliers and invested in regional stockpiles to preserve continuity of supply and mitigate lead-time variability.

Moreover, tariff-driven cost pressures spurred renewed emphasis on formulation efficiency and value engineering, encouraging R&D teams to optimize dosing regimens and concentrate formulations to reduce shipping volumes and duty exposure. In parallel, producers seeking to manage input cost volatility explored contractual hedging and long-term supplier agreements. These responses have implications for competitive positioning: firms able to localize production or demonstrate robust supply continuity gained credibility with large integrators, while those dependent on constrained import channels faced margin compression and accelerated innovation imperatives to maintain customer relationships.

Segment-level intelligence that connects product chemistries, delivery formats, livestock physiologies, and channel dynamics to reveal differentiated adoption pathways and development priorities

Insights from segmentation reveal differentiated demand drivers and development priorities across product types, livestock classes, formulation formats, applications, and distribution channels. Product-type dynamics show that acidifiers, antibiotics, beta agonists, enzymes, hormones, prebiotics, and probiotics each face unique scientific, regulatory, and market acceptance challenges; for example, acidifier research increasingly focuses on butyric, formic, and propionic acids for gut health management, while antibiotics continue to be scrutinized with ionophores, macrolides, penicillins, and tetracyclines subject to stewardship policies. Beta agonists such as ractopamine and zilpaterol remain polarizing in certain export markets, prompting manufacturers to balance efficacy claims with access constraints. Enzyme development emphasizes amylase, cellulase, phytase, and protease blends that unlock feed nutrients and improve conversion, and hormonal approaches centered on androgens, estrogens, and progestins are increasingly governed by welfare and residue considerations. Microbiome-focused solutions highlight prebiotic chemistries like fructooligosaccharides and mannan oligosaccharides and probiotic strains such as Bifidobacterium, Lactobacillus, and Saccharomyces that support disease resistance and performance.

When considering livestock type, aquaculture, poultry, ruminants, and swine present distinct physiological and management constraints that determine product selection and dosing strategies, with aquaculture's water-based delivery and poultry's rapid turnover calling for different formulation priorities than ruminant or swine systems. Formulation choices between feed additives, injectables, and water additives influence adoption pathways and veterinarian involvement, while applications across disease prevention, feed efficiency, growth promotion, and reproductive performance require tailored evidence packages and trial designs. Distribution channels comprising direct sales, distributors, and e-commerce each offer trade-offs between control, reach, and service level; for example, high-touch institutional customers may prefer direct relationships for technical support, whereas smaller farms increasingly leverage digital platforms to access packaged solutions.

Region-specific regulatory and production realities that require tailored product dossiers, localized trials, and adaptive commercialization strategies across the Americas, EMEA, and Asia-Pacific

Regional nuances materially influence regulatory tolerance, adoption rates, and strategic priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, producers and regulators display a pragmatic balance between productivity gains and stewardship obligations, often enabling pragmatic rollouts of novel feed additives alongside structured surveillance. Conversely, the Europe, Middle East & Africa region presents a heterogeneous landscape where European regulatory regimes are stringent on antibiotic use and residue limits, while several Middle Eastern and African markets present opportunities for scaling cost-effective, heat-resistant formulations adapted to local production systems. In Asia-Pacific, high-density production systems, rapid technology adoption, and strong export orientation drive demand for solutions that optimize feed conversion and biosecurity, although trade-driven constraints can complicate certain compound approvals.

These geographic dynamics influence investment and commercialization strategies. Manufacturers targeting global accounts must design adaptable dossiers to meet divergent approval pathways, and they must be prepared to differentiate labeling and support packages by region. In addition, regional research partnerships and in-market field trials are essential to demonstrate performance under local conditions and to satisfy importers and retailers who increasingly demand consistent residue and welfare evidence across sourcing geographies.

Competitive landscape analysis emphasizing R&D-backed differentiation, strategic partnerships, and supply chain resilience as decisive factors for leadership in animal performance solutions

Competitive dynamics are defined by a mix of legacy pharmaceutical firms, specialized feed additive innovators, and emerging biotech entrants. Leading players often combine robust regulatory affairs capabilities with expansive trial networks and deep relationships with integrators and veterinarians, which enables efficient pathway-to-market execution. At the same time, nimble biotech companies and ingredient specialists are advancing microbiome therapeutics, enzyme blends, and targeted acidifier technologies, creating pressure on incumbents to innovate or acquire complementary capabilities. Collaboration between large firms and niche developers has become a common strategy to accelerate time-to-evidence and broaden product portfolios.

In addition, strategic differentiation increasingly hinges on value-added services such as digital monitoring, advisory programs, and bundled nutrition plans that demonstrate holistic performance improvements. Firms that invest in high-quality clinical data, transparent residue studies, and clear use instructions gain advantage with export-oriented producers and retailers focused on compliance. Finally, supply chain resilience and the ability to localize manufacturing or source alternate inputs are emerging as competitive levers, given recent trade disruptions and raw material volatility.

Practical strategic moves for manufacturers and distributors that combine evidence generation, supply diversification, digital services, and regulatory alignment to accelerate adoption and reduce risk

Industry leaders should prioritize a set of actionable initiatives to secure commercial momentum and regulatory resilience. First, invest in rigorous, peer-reviewed field studies that demonstrate multi-dimensional value: improved feed efficiency, reduced therapeutic interventions, and robust residue profiles. Such evidence will expedite acceptance among integrators and export markets. Second, accelerate diversification of raw material sources and evaluate regional manufacturing or tolling options to mitigate tariff and transport risks. By doing so, companies can protect margins and assure customers of supply continuity.

Third, develop integrated offerings that combine product efficacy with digital monitoring and advisory services to quantify outcomes and reinforce customer loyalty. Fourth, pursue targeted collaborations with microbiome specialists, enzyme developers, and veterinary networks to expand technical breadth without bearing the full cost of discovery. Fifth, refine regulatory strategies by mapping approval pathways across priority markets and investing in harmonized safety dossiers where feasible. Taken together, these steps will position companies to deliver measurable performance improvements while managing compliance and supply-chain complexity.

A transparent, multi-source research approach combining scientific literature, regulatory analysis, field trial review, and expert practitioner interviews to ensure actionable industry insights

The research methodology underpinning this analysis combines a multi-source evidence approach, triangulating peer-reviewed scientific literature, regulatory filings, in-market field trial data, and expert interviews with veterinarians, feed formulators, and procurement leaders. Data collection emphasized studies that report controlled performance outcomes, residue testing, and comparative efficacy across formulations. In addition, the methodology incorporated qualitative inputs from supply chain and commercial leaders to understand sourcing strategies, margin pressures, and distribution preferences.

Analytical techniques included thematic synthesis of scientific findings, comparative policy analysis to map regulatory divergence across jurisdictions, and scenario planning to assess the operational impact of trade disruptions. Where available, field trial parameters were reviewed to assess statistical robustness and relevance to commercial conditions. Throughout, the approach prioritized transparent assumptions and reproducible reasoning to ensure findings are actionable for both technical and commercial audiences.

A forward-looking synthesis highlighting the necessity of rigorous evidence, resilient supply chains, and integrated service models to sustain long-term industry relevance

In conclusion, the animal growth promoters and performance enhancers sector is at an inflection point where regulatory expectations, supply-chain realities, and scientific innovation converge to redefine value creation. Success will accrue to organizations that can substantiate efficacy with rigorous data, demonstrate supply resilience in the face of trade friction, and deliver integrated solutions that align with producer economics and societal expectations. As producers demand clearer evidence of performance and as buyers increasingly factor welfare and residue considerations into sourcing decisions, product developers must adapt both their technical roadmaps and commercial narratives.

Looking ahead, the most sustainable advances will emerge from cross-disciplinary collaborations that integrate microbiome science, precision nutrition, and digital monitoring, supported by regulatory strategies that anticipate shifting approval criteria. Firms that act now to shore up evidence, localize critical inputs, and build service-oriented propositions will be best positioned to capture long-term relevance and trust across complex global value chains.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of plant-derived phytogenic feed additives as non-antibiotic growth promoters in livestock
  • 5.2. Development of precision nutrition formulations tailored to animal microbiome and growth performance
  • 5.3. Growing regulatory restrictions on antibiotic growth promoters boosting demand for alternative enhancers like probiotics and organic acids
  • 5.4. Increased investment in advanced enzyme blends to improve feed conversion and reduce environmental impact from animal production
  • 5.5. Advancement in nanotechnology-based delivery systems for targeted release of performance enhancers in poultry and swine
  • 5.6. Surge in demand for natural immunomodulators to enhance animal health and growth under intensive farming conditions
  • 5.7. Expansion of data-driven feed optimization platforms integrating real-time animal performance analytics and AI for growth promoter efficacy
  • 5.8. Emergence of gene editing technologies like CRISPR to develop livestock with superior feed efficiency and muscle growth potential
  • 5.9. Rising focus on sustainability leading to development of eco-friendly performance enhancers that reduce greenhouse gas emissions from ruminants
  • 5.10. Collaboration between biotech companies and feed manufacturers to commercialize microbial-derived bioactive peptides for growth promotion

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Growth Promoters & Performance Enhancers Market, by Product Type

  • 8.1. Acidifiers
    • 8.1.1. Butyric Acid
    • 8.1.2. Formic Acid
    • 8.1.3. Propionic Acid
  • 8.2. Antibiotics
    • 8.2.1. Ionophores
    • 8.2.2. Macrolides
    • 8.2.3. Penicillins
    • 8.2.4. Tetracyclines
  • 8.3. Beta Agonists
    • 8.3.1. Ractopamine
    • 8.3.2. Zilpaterol
  • 8.4. Enzymes
    • 8.4.1. Amylase
    • 8.4.2. Cellulase
    • 8.4.3. Phytase
    • 8.4.4. Protease
  • 8.5. Hormones
    • 8.5.1. Androgens
    • 8.5.2. Estrogens
    • 8.5.3. Progestins
  • 8.6. Prebiotics
    • 8.6.1. Fructooligosaccharides
    • 8.6.2. Mannan Oligosaccharides
  • 8.7. Probiotics
    • 8.7.1. Bifidobacterium
    • 8.7.2. Lactobacillus
    • 8.7.3. Saccharomyces

9. Animal Growth Promoters & Performance Enhancers Market, by Livestock Type

  • 9.1. Aquaculture
  • 9.2. Poultry
  • 9.3. Ruminants
  • 9.4. Swine

10. Animal Growth Promoters & Performance Enhancers Market, by Formulation

  • 10.1. Feed Additives
  • 10.2. Injectable Formulations
  • 10.3. Water Additives

11. Animal Growth Promoters & Performance Enhancers Market, by Application

  • 11.1. Disease Prevention
  • 11.2. Feed Efficiency
  • 11.3. Growth Promotion
  • 11.4. Reproductive Performance

12. Animal Growth Promoters & Performance Enhancers Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. E Commerce

13. Animal Growth Promoters & Performance Enhancers Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Animal Growth Promoters & Performance Enhancers Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Animal Growth Promoters & Performance Enhancers Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Elanco Animal Health Incorporated
    • 16.3.2. Merck & Co., Inc.
    • 16.3.3. Boehringer Ingelheim International GmbH
    • 16.3.4. Cargill, Incorporated
    • 16.3.5. Archer Daniels Midland Company
    • 16.3.6. Koninklijke DSM N.V.
    • 16.3.7. BASF SE
    • 16.3.8. Evonik Industries AG
    • 16.3.9. Alltech, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LIVESTOCK TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LIVESTOCK TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMULATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ACIDIFIERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BUTYRIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BUTYRIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BUTYRIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BUTYRIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BUTYRIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BUTYRIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROPIONIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROPIONIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROPIONIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROPIONIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROPIONIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROPIONIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY IONOPHORES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY IONOPHORES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY IONOPHORES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY IONOPHORES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY IONOPHORES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY IONOPHORES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MACROLIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MACROLIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MACROLIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MACROLIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MACROLIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PENICILLINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PENICILLINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PENICILLINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PENICILLINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PENICILLINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY TETRACYCLINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY TETRACYCLINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY TETRACYCLINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY TETRACYCLINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BETA AGONISTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RACTOPAMINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RACTOPAMINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RACTOPAMINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RACTOPAMINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RACTOPAMINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RACTOPAMINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ZILPATEROL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ZILPATEROL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ZILPATEROL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ZILPATEROL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ZILPATEROL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ZILPATEROL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AMYLASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AMYLASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AMYLASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AMYLASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AMYLASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AMYLASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY CELLULASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY CELLULASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY CELLULASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY CELLULASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY CELLULASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY CELLULASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PHYTASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PHYTASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PHYTASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PHYTASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PHYTASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PHYTASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROTEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROTEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROTEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROTEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROTEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROTEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY HORMONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANDROGENS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANDROGENS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANDROGENS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANDROGENS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANDROGENS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ANDROGENS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ESTROGENS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ESTROGENS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ESTROGENS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ESTROGENS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ESTROGENS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY ESTROGENS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROGESTINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROGESTINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROGESTINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROGESTINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROGESTINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROGESTINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FRUCTOOLIGOSACCHARIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FRUCTOOLIGOSACCHARIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FRUCTOOLIGOSACCHARIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FRUCTOOLIGOSACCHARIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FRUCTOOLIGOSACCHARIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FRUCTOOLIGOSACCHARIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BIFIDOBACTERIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BIFIDOBACTERIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BIFIDOBACTERIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY BIFIDOBACTERIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LACTOBACILLUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LACTOBACILLUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LACTOBACILLUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LACTOBACILLUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SACCHAROMYCES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SACCHAROMYCES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SACCHAROMYCES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SACCHAROMYCES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SACCHAROMYCES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SACCHAROMYCES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LIVESTOCK TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY LIVESTOCK TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AQUACULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AQUACULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AQUACULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY POULTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY POULTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RUMINANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RUMINANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RUMINANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RUMINANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RUMINANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RUMINANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SWINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SWINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SWINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY SWINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED ADDITIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED ADDITIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED ADDITIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED ADDITIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY WATER ADDITIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY WATER ADDITIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY WATER ADDITIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY WATER ADDITIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY WATER ADDITIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY WATER ADDITIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISEASE PREVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISEASE PREVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISEASE PREVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISEASE PREVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISEASE PREVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY DISEASE PREVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED EFFICIENCY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED EFFICIENCY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED EFFICIENCY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED EFFICIENCY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED EFFICIENCY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY FEED EFFICIENCY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY GROWTH PROMOTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY GROWTH PROMOTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY GROWTH PROMOTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY GROWTH PROMOTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL ANIMAL GROWTH PROMOTERS & PERFORMANCE ENHANCERS MARKET SIZE, BY RE